Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Sp 500 index funds track the S&P 500, representing large-cap U.S. stocks. They aim to mirror the index with minimal turnover.
22,112 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
When a major tariff ruling shifts import costs, retail stocks can respond quickly. This article breaks down why these...
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
February delivered a chilly stretch for investors as inflation concerns and AI headlines weighed on stock prices. Thi...
In March, fintech headlines are driving volatility and opportunity. SoFi’s latest collaboration with Mastercard on st...
As 2025 unfolds, MediWound faces a pivotal year for debt, cash, and milestones. This analysis breaks down what mediwo...
Logan Finance rolls out a premium Open Road Elevated tier to serve high-net-worth borrowers with larger loan needs ou...
Spring 2026 opens with a housing market shaped by jobs data, energy prices, and mortgage-rate swings. This article ou...
Mid-term rentals have bright potential for stable income in a shifting housing market. This guide breaks down financi...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
A New Mexico jury found Meta's platforms harmful to children's mental health, ordering a $375 million penalty and sig...